Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy.

Su-Ping GuoChen ChenZhi-Fan ZengQiao-Xuan WangWu JiangYuan-Hong Gao Hui Chang

Published in: Cancer management and research (2021)

Serum apolipoprotein A-I was found to correlate negatively with the RC response to NACRT. It could serve as a biomarker for guiding individualized treatment and a potential target for improving sensitivity to chemoradiation.

Keyphrases

rectal cancer
locally advanced
squamous cell carcinoma
radiation therapy
lymph node
climate change